All Industries
🏥
Supported

Medical Devices

ISO 13485 supplier qualification and FDA-compliant traceability for regulated supply chains.

ISO 13485:2016FDA 21 CFR Part 820EU MDR 2017/745UDI (EUDAMED)IEC 62304ISO 14971
8 weeks
Critical Supplier Qualification
Down from 6–9 months
0
FDA 483 Traceability Observations
Instant audit readiness
100%
SCN Regulatory Assessment
Zero undetected significant changes
12mo
EOL Early Warning
Optimal lifetime buy decisions

Medical device procurement is governed by the strictest regulatory frameworks in manufacturing — FDA 21 CFR Part 820, EU MDR, and ISO 13485 impose change control, traceability, and supplier qualification requirements that go far beyond general manufacturing standards. A supply chain failure in this sector risks patient safety. Proconomy provides the structured, auditable procurement workflows that regulated medical device manufacturers require.

⚠ Industry Pain Points

The S2P challenges Medical Devices companies face

These are the procurement problems that cost medical devices manufacturers time, money, and compliance risk every day.

ISO 13485 Critical Supplier Qualification Takes Too Long

Critical Risk

Qualifying a critical supplier under ISO 13485 requires documented evidence of their quality management system, audit history, process capability, and regulatory clearances — a process that routinely takes 6–9 months through manual collection. In a sector where qualified suppliers are already scarce, this bottleneck limits supply chain resilience.

Business Impact: Single-source dependency for 60%+ of critical components due to qualification backlog

UDI Component Traceability Cannot Be Systematically Enforced

Critical Risk

FDA and EU MDR require Unique Device Identifier (UDI) traceability linking each finished device to its component lot history. Without procurement and goods receipt integration, this traceability is reconstructed manually during inspections — an unreliable and resource-intensive process.

Business Impact: FDA 483 observations and EU MDR audit findings on traceability gaps

Supplier Change Notifications Require Regulatory Impact Assessment

Critical Risk

When a component supplier changes a material, process, or manufacturing site, medical device companies must assess whether the change constitutes a significant change under 21 CFR Part 820 or EU MDR — potentially requiring design validation or re-submission. Without a structured process, these assessments are informal and undocumented.

Business Impact: Undetected significant supplier changes trigger mandatory regulatory re-submission

RoHS & REACH Compliance for Medical-Grade Components Is Untracked

High Impact

Medical devices sold in the EU must comply with RoHS 3 and REACH SVHC requirements. With hundreds of components sourced from global supply chains, tracking compliance declarations for each component requires systematic supplier data collection — which most organisations still manage through annual email surveys.

Business Impact: Market access withdrawal risk for EU MDR non-compliant devices

Component Lifecycle Risk Is Ignored Until Stockouts

High Impact

When a critical component transitions to End-of-Life, the medical device company faces a stark choice: design change (requiring re-validation and potentially re-submission) or lifetime buy (requiring capital and storage). Without early warning, neither option is executed well — and production stoppage risk is high.

Business Impact: Emergency lifetime buy decisions made under pressure, overpaying by 40–60%

Conflict Minerals Declarations Cover Only Tier 1 Suppliers

High Impact

SEC conflict minerals rules and customer expectations require due diligence through the supply chain, not just at Tier 1. Most medical device companies only collect CMRT declarations from direct suppliers, leaving multi-tier exposure undisclosed.

Business Impact: Customer and investor scrutiny on incomplete conflict minerals reporting
✦ Proconomy Solutions

How Proconomy solves them

Purpose-built features and Agentic AI working together to eliminate the most costly medical devices procurement problems.

ISO 13485 Qualification & Audit Tracking

🤖 Supplier Onboarding Agent

Structured critical supplier qualification workflow aligned to ISO 13485 and FDA 21 CFR Part 820. Document collection, audit scheduling, CAPA tracking, and approval routing in a single auditable system. The Supplier Onboarding Agent identifies qualification gaps and auto-generates supplier follow-up requests.

Value DeliveredReduce critical supplier qualification from 9 months to 8 weeks

UDI Component Traceability

Lot-level traceability from purchase order through goods receipt, integrated with UDI device identification. Traceability records are immutable and linked to device history records — enabling instant response to FDA traceability requests.

Value DeliveredEliminate FDA 483 traceability observations — instant audit readiness

Supplier Change Notification Management

🤖 Lifecycle Risk Agent

Structured SCN intake workflow with mandatory regulatory impact assessment. The Lifecycle Risk Agent classifies each change, routes significant changes to the regulatory affairs team, and documents the assessment trail for inspection readiness.

Value DeliveredZero undetected significant supplier changes — full 21 CFR Part 820 compliance

Component Lifecycle & Revalidation Alerts

🤖 Lifecycle Risk Agent

Proactive EOL/NRND monitoring for every component in production BOMs. The Lifecycle Risk Agent triggers revalidation planning workflows 12 months before EOL, with lifetime buy analysis to enable optimal decision-making.

Value DeliveredMake lifetime buy decisions 12 months early — avoid emergency premium costs

RoHS & REACH Compliance for Medical Components

🤖 Supplier Onboarding Agent

Compliance attributes tracked at component level with structured supplier declaration collection. Automated annual refresh reminders. Instant evidence generation for EU MDR technical files.

Value DeliveredProduce full RoHS/REACH compliance evidence for EU MDR in hours

Conflict Minerals & Material Declarations

🤖 Supplier Onboarding Agent

CMRT collection workflow with supplier portal access and automated follow-up. Coverage reporting by commodity and supplier tier. Integrated with material declarations for FDA and EU MDR technical file requirements.

Value DeliveredAchieve 100% CMRT coverage — satisfy customer and investor audit requests
🤖 Agentic AI

AI agents working for your medical devices team

These agents run autonomously in the background — monitoring, analysing, and acting so your team doesn't have to.

🤖

Supplier Onboarding Agent

ISO 13485 qualification, compliance tracking, and CMRT management

🤖

Lifecycle Risk Agent

Component EOL monitoring and supplier change notification assessment

🤖

Sourcing Recommendation Agent

Qualified supplier sourcing with compliance pre-screening

🤖

Spend Analysis Agent

Critical component spend visibility and dual-source opportunity identification

The only Agentic AI S2P platform

Proconomy's agents don't just surface information — they act. They draft emails, flag risks, generate recommendations, and initiate workflows autonomously, so your team focuses on decisions, not data gathering.

Other industries Proconomy serves

🏥

Ready to transform medical devices procurement?

See how Proconomy's Agentic AI platform addresses the specific challenges your procurement team faces every day.